Literature DB >> 12417039

Cloning of the 5' upstream region of the rat p16 gene and its role in silencing.

Masanobu Abe1, Eriko Okochi, Takashi Kuramoto, Atsushi Kaneda, Tsuyoshi Takato, Takashi Sugimura, Toshikazu Ushijima.   

Abstract

Hypermethylation of the 5' upstream region (5' region) of the human p16(CDKN2A) (p16) gene is known to cause silencing, which is involved in a wide range of human cancers. For the rat p16 gene, its 5' region has not been cloned, and it is uncertain whether surrogate use of exon 1 alpha is adequate for analysis of p16 silencing. In this study, we observed that methylation analysis of exon 1 alpha gave false positive results in three samples of normal rat mammary epithelia and in two of six primary mammary carcinomas. Therefore, we determined the nucleotide sequence of the 5' region of the rat p16 gene. To confirm that methylation status of the 5' region is correlated with p16 expression, the methylation status was analyzed by bisulfite sequencing and methylation-specific PCR in three samples of normal mammary glands, six samples of mammary carcinomas and four cell lines. The 5' region was demethylated in all of the three normal and six carcinoma samples that fully expressed p16. On the other hand, the 5' region was highly methylated in the 3Y1 cell line, which lacked p16 expression, but without deletion. These results showed that the methylation status of the 5' region was more closely correlated with p16 expression than that of the exon 1 alpha and analysis of the methylation status is useful in examining p16 silencing in various rat tumors.

Entities:  

Mesh:

Year:  2002        PMID: 12417039      PMCID: PMC5926886          DOI: 10.1111/j.1349-7006.2002.tb01211.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  29 in total

1.  Frequent aberrant methylation of p16INK4a in primary rat lung tumors.

Authors:  D S Swafford; S K Middleton; W A Palmisano; K J Nikula; J Tesfaigzi; S B Baylin; J G Herman; S A Belinsky
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

Review 2.  p16(MTS-1/CDKN2/INK4a) in cancer progression.

Authors:  J W Rocco; D Sidransky
Journal:  Exp Cell Res       Date:  2001-03-10       Impact factor: 3.905

3.  Sequential changes in hepatocarcinogenesis induced by diethylnitrosamine plus thioacetamide in Fischer 344 rats: induction of gankyrin expression in liver fibrosis, pRB degradation in cirrhosis, and methylation of p16(INK4A) exon 1 in hepatocellular carcinoma.

Authors:  T J Park; H S Kim; K H Byun; J J Jang; Y S Lee; I K Lim
Journal:  Mol Carcinog       Date:  2001-03       Impact factor: 4.784

Review 4.  Review article: the stages of gastrointestinal carcinogenesis--application of rodent models to human disease.

Authors:  H C Pitot; H Hikita; Y Dragan; L Sargent; M Haas
Journal:  Aliment Pharmacol Ther       Date:  2000-04       Impact factor: 8.171

5.  High incidence of allelic loss on chromosome 5 and inactivation of p15INK4B and p16INK4A tumor suppressor genes in oxystress-induced renal cell carcinoma of rats.

Authors:  T Tanaka; Y Iwasa; S Kondo; H Hiai; S Toyokuni
Journal:  Oncogene       Date:  1999-06-24       Impact factor: 9.867

6.  Preferential induction of guanine deletion at 5'-GGGA-3' in rat mammary glands by 2-amino- 1-methyl-6-phenylimidazo[4,5-b]pyridine.

Authors:  E Okochi; N Watanabe; Y Shimada; S Takahashi; K Wakazono; T Shirai; T Sugimura; M Nagao; T Ushijima
Journal:  Carcinogenesis       Date:  1999-10       Impact factor: 4.944

7.  INK4a gene expression and methylation in primary breast cancer: overexpression of p16INK4a messenger RNA is a marker of poor prognosis.

Authors:  R Hui; R D Macmillan; F S Kenny; E A Musgrove; R W Blamey; R I Nicholson; J F Robertson; R L Sutherland
Journal:  Clin Cancer Res       Date:  2000-07       Impact factor: 12.531

8.  The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.

Authors:  F J Stott; S Bates; M C James; B B McConnell; M Starborg; S Brookes; I Palmero; K Ryan; E Hara; K H Vousden; G Peters
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

9.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

Authors:  J G Herman; J R Graff; S Myöhänen; B D Nelkin; S B Baylin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

10.  Presence of p53 mutations in 3Y1-B clone 1-6: a rat cell line widely used as a normal immortalized fibroblast.

Authors:  T Ushijima; H Makino; M Nakayasu; S Aonuma; M Takeuchi; K Segawa; T Sugimura; M Nagao
Journal:  Jpn J Cancer Res       Date:  1994-05
View more
  1 in total

1.  Methylation of the BIN1 gene promoter CpG island associated with breast and prostate cancer.

Authors:  Ekaterina B Kuznetsova; Tatiana V Kekeeva; Sergei S Larin; Valeria V Zemlyakova; Anastasiya V Khomyakova; Olga V Babenko; Marina V Nemtsova; Dmitry V Zaletayev; Vladimir V Strelnikov
Journal:  J Carcinog       Date:  2007-05-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.